Janssen Submits Additional Marketing Applications for ZYTIGA® in the European Union and in the U.S.
Beerse, Belgium And Raritan, New Jersey (ots/PRNewswire) - ? Simultaneous Submissions Based on Data from Pre-chemo Prostate Cancer Study Janssen-Cilag International NV announced today it has submitted a type II variation to the European Medicines Agency (EMA) for ZYTIGA(R); simultaneously, Janssen Research & ...
mehr